Penicillin G acylase (PGA) is intended to be used for cleavage of phenylacetamide containing linkers. Sufficient amounts of enzyme have to be produced to investigate the enzyme´s ability to cleave different linkers. The PGA from E. coli ATCC11105 has been shown to be able to hydrolyse phenylacetamide containing linkers, although the cleavage efficiency has to be highly improved. A possible alternative to the E. coli enzyme is the PGA from A. faecalis ATCC19018. The enzymes show remarkable differences in their substrate spectra, their temperature stability, and activity in alkaline solutions. It can be assumed that both enzymes differ in their ability to cleave phenylacetamide containing linkers. The PGAs from E. coli ATCC11105 and A. faecalis were cloned into low copy plasmids. Both enzymes could be produced constitutively in E. coli strains containing these plasmids. Efficient production systems for recombinant PGAs from E. coli ATCC11105 and A. faecalis19018 have been established. The PGA from E. coli can be produced with enzyme activities that are at least equivalent to activities described in literature. The production of the A. faecalis enzyme was found to be even more effective. The recombinant PGAs can now be tested for their ability to cleave different phenylacetamide containing linkers. These expression systems offer the possibility for large scale production of PGA after optimisation of the fermentation conditions and downstream processing. As PGA is not only an useful enzyme for the objectives within this project it might be of potential interest to other users as well. Examples for the application of PGA which can be found in the literature cover the enzymatic synthesis of semisynthetic antibiotics, cleavage of racemates or application for protecting group techniques. First results on substrate mapping can be used to predict the enzymes selectivity.